Your browser is no longer supported. Please, upgrade your browser.
Settings
FOLD Amicus Therapeutics, Inc. daily Stock Chart
FOLD [NASD]
Amicus Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.49 Insider Own0.90% Shs Outstand139.06M Perf Week1.82%
Market Cap1.01B Forward P/E- EPS next Y-1.06 Insider Trans43.45% Shs Float88.95M Perf Month2.69%
Income-200.00M PEG- EPS next Q-0.36 Inst Own97.60% Short Float41.26% Perf Quarter36.47%
Sales5.00M P/S201.92 EPS this Y-23.80% Inst Trans0.03% Short Ratio12.96 Perf Half Y1.54%
Book/sh2.53 P/B2.87 EPS next Y20.30% ROA-21.40% Target Price11.07 Perf Year-9.59%
Cash/sh2.38 P/C3.06 EPS next 5Y35.00% ROE-59.60% 52W Range4.41 - 9.61 Perf YTD46.08%
Dividend- P/FCF- EPS past 5Y-3.00% ROI-37.20% 52W High-23.00% Beta1.73
Dividend %- Quick Ratio3.00 Sales past 5Y-25.40% Gross Margin83.20% 52W Low67.80% ATR0.29
Employees263 Current Ratio3.10 Sales Q/Q- Oper. Margin- RSI (14)59.49 Volatility3.18% 4.04%
OptionableYes Debt/Eq0.00 EPS Q/Q-19.90% Profit Margin- Rel Volume0.41 Prev Close7.26
ShortableYes LT Debt/Eq0.43 EarningsMay 31 BMO Payout- Avg Volume2.83M Price7.40
Recom1.70 SMA203.36% SMA506.67% SMA20010.23% Volume933,369 Change1.93%
Jan-24-17Upgrade Robert W. Baird Neutral → Outperform $7 → $10
May-18-16Initiated BofA/Merrill Buy $10
Apr-14-16Initiated Robert W. Baird Neutral $9
Apr-12-16Reiterated Chardan Capital Markets Buy $10 → $15
Sep-16-15Downgrade Chardan Capital Markets Buy → Neutral $17
Jun-16-15Reiterated Chardan Capital Markets Buy $14 → $17.50
May-29-15Initiated Chardan Capital Markets Buy $14
Dec-20-12Reiterated Canaccord Genuity Buy $11 → $6
Dec-20-12Downgrade Capstone Investments Buy → Hold $3
Nov-01-12Initiated Capstone Investments Buy $7
Apr-06-10Initiated Canaccord Adams Buy
Mar-31-10Initiated Leerink Swann Mkt Perform
Oct-05-09Downgrade Wedbush Morgan Outperform → Underperform $17 → $3.50
Mar-20-09Initiated Wedbush Morgan Buy $17
Feb-27-09Reiterated Lazard Capital Buy $18 → $15
Jul-23-08Reiterated Lazard Capital Buy $13 → $21
May-14-08Reiterated Lazard Capital Buy $15 → $13
Jan-04-08Reiterated Lazard Capital Buy $18 → $15
Nov-08-07Reiterated Lazard Capital Buy $20 → $22
Jul-10-07Initiated Pacific Growth Equities Buy
Apr-06-17 08:15AM  Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day GlobeNewswire
Apr-03-17 08:01AM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study GlobeNewswire
Mar-17-17 09:30AM  Today's Research Reports on Biotech Stocks to Watch: Amicus Therapeutics and Sarepta Therapeutics Accesswire
Mar-16-17 10:41AM  Are These 2 Biotechs Diamonds in the Rough? Motley Fool
Mar-08-17 04:01PM  Amicus Therapeutics Launches Galafold (Migalastat) for Treatment of Fabry Disease in Italy GlobeNewswire
07:47AM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-07-17 01:55PM  Harry Boxers six biotechnology stocks to watch MarketWatch -8.84%
01:04PM  AMICUS THERAPEUTICS INC Financials
Mar-03-17 09:09AM  Four biotech stocks surging on optimism about drug trials, product launches MarketWatch
Mar-02-17 03:34PM  Biotechs Breaking Out On Drug Development News Forbes
01:15PM  Amicus Therapeutics, Inc. (FOLD) Could Be The Force That Brings Change To The FDA Insider Monkey
09:30AM  Dow Soars Above 21,000 for the First Time in History: Today's Reports on Clean Energy Fuels and Amicus Therapeutics Accesswire
07:30AM  Amicus Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire
Mar-01-17 11:22PM  Edited Transcript of FOLD earnings conference call or presentation 1-Mar-17 1:30pm GMT +17.10%
06:43PM  Pompe drug lauded by Trump costs $300,000 a year Reuters
05:51PM  Trump's latest comments are 'constructive' for drug industry: Amicus Therapeutics CEO at CNBC
04:52PM  Amicus Therapeutics CEO: Trump constructive for our indus...
04:50PM  Why Amicus Therapeutics, Inc. Jumped Higher Today at Motley Fool
11:35AM  4 Biopharma Stocks Moving the Market on Wednesday
10:38AM  Trump wants to upend the 'slow and burdensome' drug approval process at the FDA here's what the agency actually does
09:16AM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
08:12AM  Amicus CEO John Crowley, Not His Daughter Megan, Might Compel Trump to Make Big Changes at FDA
07:07AM  Q4 2016 Amicus Therapeutics Inc Earnings Release - Before Market Open
07:00AM  Amicus Therapeutics Announces Full-Year 2016 Financial Results and Corporate Updates GlobeNewswire
Feb-28-17 09:55AM  Amicus Therapeutics Launches Galafold in UK at Investopedia
Feb-27-17 08:00AM  Amicus Therapeutics Launches Galafold (Migalastat) for Treatment of Fabry Disease in the United Kingdom GlobeNewswire +7.89%
Feb-23-17 09:30AM  Could 2017 Prove to be a Bull Market for Biotechs? Today's Reports on Depomed and Amicus Therapeutics Accesswire
06:00AM  These Small Biotechs Are Poised to Go Higher at Investopedia
Feb-22-17 05:36PM  Amicus Therapeutics to Announce Full-Year 2016 Financial Results and Corporate Updates on March 1, 2017 GlobeNewswire
Feb-16-17 07:17AM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Feb-15-17 07:30PM  Amicus Therapeutics Presents Additional Positive Preliminary Phase 1/2 Data at WORLDSymposium 2017 GlobeNewswire
12:49PM  Amicus Therapeutics Updates Migalastat Drug at Investopedia
08:42AM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  Amicus Therapeutics Presents Important New Scientific Findings and Preclinical Data for Pompe Program at WORLDSymposium 2017 GlobeNewswire
Feb-14-17 07:30PM  Amicus Therapeutics Highlights New Fabry Program Data at WORLDSymposium 2017 GlobeNewswire
Feb-09-17 04:03PM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
Feb-06-17 07:30AM  Amicus Therapeutics to Present at the Leerink Partners 6th Annual Global Healthcare Conference GlobeNewswire
Jan-24-17 09:26AM  Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo
07:30AM  Amicus Therapeutics Announces Presentations and Posters at 13th Annual WORLDSymposium 2017 GlobeNewswire
06:48AM  Amicus Therapeutics upgraded by Robert W. Baird
Jan-09-17 07:30AM  Amicus Therapeutics Provides Full-Year 2017 Strategic Outlook and Financial Guidance GlobeNewswire
07:08AM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
Jan-08-17 10:10AM  Huge Energy Trade Kicks Off 2017 Insider Buying: DCP Midstream, Och-Ziff Capital, TransEnterix, Amicus Therapeutics and More
Jan-04-17 07:30AM  National Institute for Health and Care Excellence (NICE) Issues Final Positive Recommendation for Galafold (migalastat) for Fabry Disease in England GlobeNewswire +9.75%
Jan-01-17 12:40PM  5 Stocks Insiders Love Right Now
Dec-30-16 04:20PM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
Dec-23-16 11:22AM  Trump, Interest Rates And Biotech Investing In 2017 at Forbes +10.15%
07:30AM  Amicus Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-22-16 04:04PM  Abercrombie, OvaScience Slide Into Thursdays 52-Week Low Club at 24/7 Wall St.
02:02PM  Amicus Therapeutics, Inc. (FOLD) Announces The Closure Of Its Senior Convertible Notes at Insider Monkey
Dec-21-16 05:28PM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Def
04:01PM  Amicus Therapeutics Announces Closing of Offering of Senior Convertible Notes and Exercise in Full of Option to Purchase Additional Notes GlobeNewswire
09:15AM  Today's Reports on Biotech Movers Ariad Pharmaceuticals and Amicus Therapeutics Accesswire
Dec-16-16 04:04PM  Abercrombie & Fitch, Hanesbrands Dip into Fridays 52-Week Low Club at 24/7 Wall St.
06:03AM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Dec-15-16 08:45PM  Amicus Therapeutics Announces Pricing of Offering of Convertible Senior Notes GlobeNewswire -17.95%
11:51AM  Amicus Therapeutics, Inc. (FOLD): Breaking Down The Raise at Insider Monkey
08:42AM  Why Amicus Therapeutics Stock Is Sinking Today at Motley Fool
Dec-14-16 05:12PM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:01PM  Amicus Therapeutics Announces Proposed Offering of Convertible Senior Notes GlobeNewswire
11:44AM  ETFs with exposure to Amicus Therapeutics, Inc. : December 14, 2016
Dec-12-16 05:00PM  Hedge Funds Are Betting On James River Group Holdings Ltd (JRVR) at Insider Monkey
Dec-09-16 10:03AM  Is Amicus Therapeutics a Bad-News Buy? at Motley Fool
Dec-08-16 08:36AM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Amicus Therapeutics Announces Positive Preliminary Data from Phase 1/2 Study of Novel Treatment Paradigm for Pompe Disease GlobeNewswire
Dec-07-16 02:10AM  Is Amicus Therapeutics, Inc. (FOLD) A Good Stock To Buy? at Insider Monkey
Dec-06-16 04:19PM  The Latest Buzz in Biotech at Motley Fool
Dec-03-16 09:25AM  6 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Dec-01-16 02:28PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Amicus Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
11:42AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amicus Therapeutics, Inc. - FOLD PR Newswire
11:03AM  ETFs with exposure to Amicus Therapeutics, Inc. : December 1, 2016
Nov-30-16 09:40AM  Amicus Fabry Disease Drug Delayed to 2020 (FOLD) at Investopedia -8.14%
07:35AM  Amicus Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : FOLD-US : November 30, 2016
07:13AM  Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for Juno
Nov-29-16 05:06PM  Amicus Provides Regulatory Update on Fabry Disease Drug -21.75%
04:44PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amicus Therapeutics, Inc. (FOLD) PR Newswire
04:14PM  Biotech Movers And Shakers: Nivalis Therapeutics Inc (NVLS) And Amicus Therapeutics, Inc. (FOLD) at Insider Monkey
03:44PM  FDA Requests Additional Data on Amicus Fabry Disease Treatment
01:35PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Amicus Therapeutics, Inc. Business Wire
01:11PM  Why Amicus Therapeutics Shares Are Crashing 21.8% Today at Motley Fool
Nov-28-16 09:52PM  Futures Flat as Investors Take Profits; Asia Mixed -6.52%
05:25PM  Amicus shares drop 28% after FDA denies quick drug approval at MarketWatch
04:48PM  AMICUS THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
04:34PM  Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan
04:10PM  Amicus Therapeutics Announces U.S. Regulatory Pathway for Migalastat for Fabry Disease GlobeNewswire
Nov-15-16 12:27PM  Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks? at Insider Monkey
Nov-11-16 07:30AM  Journal of Medical Genetics Publishes Pivotal Phase 3 ATTRACT Study of Migalastat for Patients with Fabry Disease GlobeNewswire
Nov-09-16 12:48PM  ETFs with exposure to Amicus Therapeutics, Inc. : November 9, 2016 +9.89%
Nov-08-16 04:51PM  Biotech Gainers On Tuesday: Amicus Therapeutics, Inc. (FOLD) And Ionis Pharmaceuticals Inc (IONS) at Insider Monkey +6.19%
12:53PM  Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors Q3 Returns; See How Other Investments Performed at Insider Monkey
09:30AM  Amicus 3Q Loss $47M or 32 Cents a Share (FOLD) at Investopedia
07:54AM  Amicus Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : FOLD-US : November 8, 2016
Nov-07-16 04:43PM  Edited Transcript of FOLD earnings conference call or presentation 7-Nov-16 1:30pm GMT +21.01%
03:22PM  Here's Why Amicus Therapeutics, Inc. Soared As Much As 20% Despite an Earnings Miss at Motley Fool
Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its principal product is the migalastat HCl, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease, which has completed two global Phase III registration studies. The company is also developing SD-101, which is in Phase III clinical study for the treatment of the genetic connective tissue disorder epidermolysis bullosa; and AT3375 to treat Parkinson's disease. It is conducting a Phase 1/2 clinical study of ATB200-02 to investigate pompe treatment paradigm in pompe patients. The company has strategic alliance with GlaxoSmithKline plc to develop and commercialize migalastat as a monotherapy and in combination with ERT for Fabry disease. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campbell Bradley LChief Operating OfficerMar 02Sale8.0049,050392,400127,475Mar 03 07:25 PM
Do HungChief Science OfficerFeb 07Sale6.0025,000150,000534,266Feb 09 04:35 PM
Do HungChief Science OfficerJan 13Sale6.0025,000150,000559,266Jan 17 04:14 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 30Buy4.9694,750470,05516,293,847Jan 04 02:25 PM
PERCEPTIVE ADVISORS LLC10% OwnerDec 29Buy4.8594,750459,91716,293,847Dec 30 08:45 AM
PERCEPTIVE ADVISORS LLC10% OwnerDec 28Buy4.9147,375232,70616,199,097Dec 30 08:45 AM
PERCEPTIVE ADVISORS LLC10% OwnerDec 23Buy4.8185,275410,05016,151,722Dec 27 10:57 AM
PERCEPTIVE ADVISORS LLC10% OwnerDec 22Buy4.51189,500854,83516,066,447Dec 23 08:31 AM
Quimi DaphneSVP, FinanceNov 09Option Exercise8.002,85822,86427,047Nov 10 04:07 PM
Quimi DaphneSVP, FinanceNov 09Sale8.008,54668,36824,189Nov 10 04:07 PM
Do HungChief Science OfficerNov 01Sale7.0025,000175,000533,453Nov 03 04:07 PM
Do HungChief Science OfficerOct 03Sale7.2525,000181,250558,453Oct 04 08:21 PM
Baird William D IIIChief Financial OfficerSep 20Option Exercise8.003,50028,00056,450Sep 22 04:09 PM
Baird William D IIIChief Financial OfficerSep 20Sale8.0020,500164,07535,950Sep 22 04:09 PM
Do HungChief Science OfficerSep 06Sale7.0025,000175,000583,453Sep 08 04:08 PM
PERCEPTIVE ADVISORS LLCNo longer a 10% Owner.Aug 25Sale6.811,100,0007,491,00014,139,444Aug 26 04:30 PM
Do HungChief Science OfficerAug 04Sale7.0025,000175,000608,453Aug 08 04:28 PM
Barth JayChief Medical OfficerAug 04Sale7.0010,45873,20615,000Aug 08 04:28 PM
Barth JayChief Medical OfficerJul 27Sale7.0020,916146,41225,458Jul 29 05:26 PM
Redmile Group, LLC10% OwnerJun 03Buy7.2066,300477,36012,956,446Jun 13 07:11 PM
Rosenberg EllenGeneral Counsel & Corp. SecyJun 02Buy7.6715,000115,05015,000Jun 06 04:08 PM